Last edition
News about
Sanofi's Efdoralprin Alfa Gains EU Orphan Designation for AATD Emphysema
Sanofi’s investigational restorative recombinant therapy efdoralprin alfa has received EU orphan drug designation for alpha-1 antitrypsin deficiency–related emphysema, following positive phase II head-to-head results demonstrating success across all primary and key secondary endpoints versus the current plasma-derived standard of care.
Symbiotec Pharmalab Files Draft Papers to Raise INR 2,180 Crore via IPO
Symbiotec Pharmalab Ltd has filed draft red herring prospectus papers with the Securities and Exchange Board of India to raise INR 2,180 crore through an initial public offering.
Cue Biopharma Prices USD 10 Million Public Offering
Cue Biopharma has priced a USD 10 million public offering, with gross proceeds expected to be approximately USD 10 million before underwriting discounts, commissions, and other offering-related expenses.
PM Narendra Modi Addresses Closing Ceremony of 2nd WHO Global Summit on Traditional Medicine
Addressing the closing ceremony of the Second WHO Global Summit on Traditional Medicine, Prime Minister Narendra Modi highlighted India’s leadership in traditional healthcare, the global impact of yoga and the establishment of key WHO institutions in Jamnagar and Delhi
Ambros Therapeutics Launches with USD 125 Million Series A to Advance CRPS Therapy
Ambros Therapeutics has launched with a USD 125 million Series A financing to advance neridronate for Complex Regional Pain Syndrome Type 1, supported by multiple FDA designations and an oversubscribed round led by RA Capital Management and Patient Square Capital, with a pivotal phase III trial planned for early 2026.
Takeda Becomes a BaseLaunch Partner
BaseLaunch has added Takeda as a new pharmaceutical partner to its biotech venture incubator, expanding its network of global pharma backers supporting and funding early-stage drug development startups.
Zydus Lifesciences Inks Exclusive Deal with Myriad Genetics for Cancer Risk Tests in India
Zydus Lifesciences has entered into an exclusive agreement with US-based Myriad Genetics to introduce clinically validated cancer-risk assessment diagnostic tests in India, aimed at enabling personalised, evidence-based cancer care and strengthening early detection and preventive oncology efforts in the country.
TempraMed Opens New Florida Manufacturing Facility to Boost Output and Cut Costs
TempraMed Technologies Ltd, a medical technology company focused on improving the storage and management of temperature-sensitive medications, has opened an additional manufacturing facility in Florida, strengthening its production footprint in the United States.
WHO Hosts 2nd Global Summit to Promote Innovation and Integration in Traditional Medicine
The World Health Organization’s second Global Summit on Traditional Medicine has convened global leaders, scientists and indigenous practitioners from over 100 countries, with key scientific initiatives and new commitments expected to advance the WHO Global Traditional Medicine Strategy 2025–2034.
Pfizer and Cipla Form Exclusive Marketing Partnership for Select Brands in India
Pfizer and Cipla have joined forces in an exclusive marketing and distribution agreement for select brands in India. The collaboration aims to improve access and availability of these key medicines, ensuring patients across the country benefit from a wider reach and streamlined supply.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy